IP Library Granted Patent US 9,005,974
Granted Patent B2
US 9,005,974 · App. 12/086,269 · Granted Apr 14, 2015

Means and methods for influencing the stability of cells

Inventor: Hergen Spits (San Francisco, CA)
Assignees: Academish Medisch Centrum Bij de Universiteit van Amsterdam; AIMM Therapeutics B.V.
C12N5/0635C12N2501/23C12N2501/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,005,974
App. No.
12/086,269
Granted
Apr 14, 2015
Kind
B2
Abstract

The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp 1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.

Claims (17)

1. A method for increasing the replicative life span of an antibody producing cell having a potential for expression of an amount of BCL6 and/or Blimp-1 expression, the method comprising:

providing the antibody producing cell with a nucleic acid molecule encoding a peptide comprising BCL6; and

increasing an expression level of Blimp-1 in the antibody producing cell by culturing the antibody producing cell in the present of IL-21 and/or IL-10, or by providing the antibody producing cell with STAT3.

2. The method according to claim 1 , wherein BCL6 and Blimp-1 are co-expressed in the antibody producing cell.

3. The method according to claim 1 , wherein the antibody producing cell produces antibodies against an antigen of interest.

4. The method according to claim 3 , wherein the antibody producing cell has been obtained from an individual, which individual had been previously exposed to the antigen of interest.

5. The method according to claim 1 , further comprising expressing a gene of the antibody producing cell encoding the Ig heavy chain and/or Ig light chain in a second cell.

6. A method for increasing the replicative life span of an antibody producing cell, which antibody producing cell co-expresses BCL6 and/or Blimp-1, the method comprising:

providing the antibody producing cell with a nucleic acid molecule encoding a peptide comprising BCL6; and

increasing an expression level of Blimp-1 in the antibody producing cell by culturing the antibody producing cell in the presence of IL-21 and/or IL-10, or by providing the antibody producing cell with STAT3;

wherein the antibody producing cell produces antibodies against an antigen of interest.

7. The method according to claim 6 , wherein the antibody producing cell is from a subject previously exposed to the antigen of interest.

8. A method for inclueasing an antibody producing cell's replicative life span, the method comprising:

providing a B cell with a polynucleotide encoding a peptide comprising the BCL6 to enhance the B cell's stability; and

culturing the B cell with IL-21, IL-10, and/or STAT3 to increase expression of Blimp-1 in the B cell,

so as to increase the B cell's replicative life span.

9. The method according to claim 1 , wherein the BCL6 forms a fusion protein.

Assignments (4)
CHANGE OF NAME Recorded Dec 9, 2024
From: ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM
To: STICHTING AMSTERDAM UMC
Reel/Frame 069536/0408 →
CHANGE OF NAME Recorded Sep 11, 2024
From: ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM
To: STICHTING AMSTERDAM UMC
Reel/Frame 071410/0305 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2021
From: AIMM THERAPEUTICS B.V.
To: KLING BIOTHERAPEUTICS B.V.
Reel/Frame 055711/0534 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2009
From: SPITS, HERGEN
To: ACADEMISH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM; AIMM THERAPEUTICS B.V.
Reel/Frame 023625/0369 →
Continuity (1)
Related Publication 20100093038A1 · Apr 15, 2010